7Baggers
Quarterly
Annual
    Unit: USD2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 
      
    		                          
      cash flows from operating activities:
    		                          
      net income
    		-5,064,042 -5,850,132 -7,592,408 -8,408,818 -5,927,620 -4,037,916 -5,383,809 -3,968,102 -2,241,699 -2,427,515 -13,743,003 -1,950,503 -1,314,033 -1,562,778 -1,336,522 -570,648 -455,204 -595,694 -590,593 -424,434 -654,148 -701,454 -634,345 -666,893 -637,043 -621,813 
      adjustments to reconcile net income to net cash from operating activities:
    		                          
      depreciation and amortization expense
    		                          
      stock-based compensation expense
    		101,640 157,736 261,458 297,947 269,513 246,039   207,178 205,151   122,031 76,790 40,463 6,000 12,000 6,000 36,756 32,348 105,172 153,224 194,299 142,512 80,364 52,549 
      changes in assets and liabilities:
    		                          
      accounts receivable
    		                          
      prepaid expenses and other current assets
    		112,385 -677,033 592,596 -8,299 57,188 -755,973 85,834 -312,052 -801,119 -138,368 -123,249 70,928 392 35,659 -106,976 27,424 27,425 27,425 27,426 -83,607 0 -30 -26,064 20,849 20,847 20,848 
      other assets
    		224,681 882,097 0 10,000 0 976,498                     
      accounts payable and accrued expenses
    		  -3,561,804 2,996,173    1,421,537 -133,235 -1,934,257 7,099,710 -23,372 91,773 -357,878 -114,080 87,954 -490,479 654,561 208,112 169,106 -5,401 267,465 66,706 233,611 145,697 107,105 
      total adjustments
    		3,122,994 166,402 -2,685,537 3,313,140 -109,524 275,044 -1,680,427 168,948 -1,591,879 -1,905,725 7,059,854 316,798 55,494 -58,249 -205,429 287,522 -111,669 237,074 309,833 80,506 197,700 384,093 132,804 387,166 256,858 240,240 
      net cash from operating activities
    		-1,941,048 -5,683,730 -10,277,945 -5,095,678 -6,037,144 -3,762,872 -7,064,236 -3,799,154 -3,833,578 -4,333,240 -6,683,149 -1,633,705 -1,258,539 -1,621,027 -1,541,951 -283,126 -566,873 -358,620 -280,760 -343,928 -456,448 -317,361 -501,541 -279,727 -380,185 -381,573 
      capex
    		0 0 0 0 0 0 0 0 0 0 0 0 0 0 -154,321 0 0 0 -3,334 0 0 -4,272 0 0 0 0 
      free cash flows
    		-1,941,048 -5,683,730 -10,277,945 -5,095,678 -6,037,144 -3,762,872 -7,064,236 -3,799,154 -3,833,578 -4,333,240 -6,683,149 -1,633,705 -1,258,539 -1,621,027 -1,696,272 -283,126 -566,873 -358,620 -284,094 -343,928 -456,448 -321,633 -501,541 -279,727 -380,185 -381,573 
      cash flows from investing activities:
    		                          
      purchase of equipment
    		  -18,949 -6,192   0 -51,875 -20,197 -62,186                 
      net cash from investing activities
    		  -18,949 -6,192   0 -51,875 -20,197 -62,186 0 -27,789   -154,321    -3,334 0 0 -4,272     
      cash flows from financing activities:
    		                          
      net proceeds from issuance of notes payable – related parties
    		                          
      net proceeds from sale of common stock and warrants
    		      0   9,229,248 0    0            
      net proceeds from warrant exercise
    		         24                 
      net cash from financing activities
    		      0 7,625,543 18,498,513 9,229,272 0 230,000 -25,801 12,580,013 -526 11,155,508 1,055,748 297,086 -1,924 696,876 496,874 237,917 250,000 600,000   
      net decrease in cash and cash equivalents
    		792,853 -5,683,730                         
      cash and cash equivalents at beginning of period
    		0 6,452,589 0 0 0 27,612,732 0 0 0 11,423,870 0 0 0 9,883,796 0 0 0 283,341 0 0 0 259,701 0 0 0 312,727 
      cash and cash equivalents at end of period
    		792,853 768,859 -6,234,452 -5,101,870 -6,060,949 23,849,860 -7,064,236 3,774,514 14,644,738 16,257,716 -6,683,149 -1,431,494 -1,304,269 20,842,782 -1,696,798 10,869,912 488,875 221,807 -286,018 352,948 40,426 175,985 -251,541 320,273 -380,185 571,154 
      depreciation expense
    		 19,576  17,319 17,318 17,319    12,269                 
      accounts payable, accrued expenses and other liabilities
    		 -215,974    -208,839                     
      none
    		                          
      depreciation and amortization
    		      14,071 17,675   11,715 8,935 13,354 4,517 16,673 -4,050 6,039 994 2,657 1,898 1,898 1,897 4,920 4,951 4,950 4,980 
      grant funds receivables
    		                          
      net proceeds from warrant exercises
    		      0 7,625,543   0 230,000 0 3,174,156             
      net increase in cash and cash equivalents
    		  -6,234,452 -5,101,870 -6,060,949 -3,762,872 -7,064,236 3,774,514 14,644,738 4,833,846 -6,683,149 -1,431,494 -1,304,269 10,958,986 -1,696,798 10,869,912 488,875 -61,534 -286,018   -83,716  320,273 -380,185 258,427 
      grant funds receivable
    		                       -14,757   
      warrant issued for technology license
    		                          
      gain on debt extinguishment
    		          0 0               
      repurchase of preferred stock
    		          0 0               
      principal repayment of note payable
    		          0 0 -24,801 -3,063  -2,988 -2,952 -2,914  -3,124 -3,126 -2,083     
      stock-based compensation expense for employees and directors
    		                          
      stock-based compensation expense for consultants
    		                          
      grant funds and other receivables
    		       0 99,526 -50,520 -49,006 0 0 182,663 -41,509 46,009 333,346 -451,906 34,882 -39,239 96,031 -38,463    54,758 
      deposits and other assets
    		       -1,196,778                   
      cash flows from investing activities
    		                          
      net proceeds from sale of common stock
    		            0 9,408,920             
      amortization of debt discount
    		              0            
      warrant issued for technology license fee
    		          0                
      purchase of property and equipment
    		          0    -154,321    -3,334 0 0 -4,272     
      net proceeds from sale of preferred stock
    		              0 0 0 300,000 0 700,000 500,000 240,000 0 600,000 0 590,000 
      net proceeds from issuance of note payable
    		              0 0           
      net proceeds from bridge financing
    		              0 0           
      stock-based compensation for employees and directors
    		                          
      stock-based compensation for consultants
    		                          
      principal repayment of notes payable
    		                          
      proceeds from issuance of notes payable
    		                          
      proceeds from issuance of note payable
    		                       0 0 50,000 
      net cash provided in financing activities
    		                         640,000 
      stock-based compensation expense, including common stock issued for services
    		                          
      proceeds from sale of common stock
    		                          
      proceeds from sale of preferred stock
    		                          
      accretion of preferred stock redemption value
    		                          
      deferred offering costs
    		                          
      deposits
    		                          
      proceeds from sale of property and equipment
    		                          
      net cash provided (used) by investing activities
    		                          
      supplemental disclosure of cash flow information interest paid
    		                          
      write-off of deferred offering costs
    		                          
      supplemental disclosure of cash flow information
    		                          
      interest paid
    		                          
      supplemental disclosure of non-cash investing and financing activities:
    		                          
      adjustments to reconcile net income to net cash from operating activities
    		                          
      changes in assets and liabilities
    		                          
      net cash provided (used) by financing activities
    		                          
      stock subscriptions receivable
    		                          
      in connection with the merger discussed in note 6, all of the outstanding shares of the company’s mandatory redeemable convertible preferred stock were converted into shares of common stock as of september 28, 2006.
    		                          
      unearned grant revenue
    		                          
      net proceeds from exercise of stock options
    		                          
      prepaid expenses
    		                          
      repayment of note payable
    		                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.